Moderna sues Pfizer and BioNTech over Covid-19 vaccine
Moderna on Friday sued Pfizer and BioNTech, its main rivals in the mRNA Covid vaccine race, for allegedly infringing on its patents, the latest and perhaps most significant in a series of intellectual property disputes over the technology behind the world-changing and astoundingly lucrative shots.
In its complaint, the Cambridge, Mass.-based company said it is not seeking damages prior to March 8, 2022, before which the company said it would not enforce its patents because of the Covid-19 public health emergency. It is also not seeking damages in 92 low- and middle- income countries where Moderna said it would continue to not enforce its patents.
Read Original Article: Moderna sues Pfizer and BioNTech over Covid-19 vaccine »
